Aug 11, 2022 / 08:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the Onconova Therapeutics Second Quarter 2022 Financial Results and Business Update Conference Call. (Operator Instructions) As a reminder, this call is being recorded today, August 11, 2022.
At this time, I'd like to turn the call over to Bruce Mackle of LifeSci Advisors. Please go ahead.
Bruce Mackle -
Thank you, operator, and welcome, everyone, to Onconova's Second Quarter 2022 Financial Results and Business Update Conference Call. Earlier this afternoon, Onconova issued a press release reporting its financial results and business progress. If you have not yet seen this press release, it is available in the Investors & Media section of the company's website at www.onconova.com.
Following my introduction, Onconova President and CEO, Dr. Steve Fruchtman, will provide an overview of the company's recent highlights and future outlook; followed by Chief Medical Officer, Dr. Mark Gelder, who will discuss progress across
Q2 2022 Onconova Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot